Company: RVRC
Filing Date: 2025-08-13
Form Type: S-1/A
Source: 0001213900-25-075747
Chunk: 207

Company: Revium Rx.
Filing Date: 2025-08-13
Form: S-1/A
Chunk 207
---
 (the “Plan Amendment”). The Plan Amendment became effective on the date of the approval by the Board of Directors, but it is subject to approval by the holders of a majority of the voting power of the Company within 12 months, pursuant to section 422(b)(1) of the Internal Revenue Code. |

| 2. | A grant to the Successor’s former Chief Executive Officer 3,800,000 stock options at an exercise price of $0.001 per share. 1,900,000 options were fully vested upon grant and the remaining 1,900,000 options are scheduled to vest on a quarterly basis over two years in equal quarterly instalments of 237,500 options, beginning with the quarter ended March 31, 2024. The options are exercisable within eight years from grant date. The aggregate grant date fair value of such options was approximately $4,770. |

| 3. | A grant to the Chairman of the Board 160,000 stock options at an exercise price of $0.40 per share. 80,000 options were fully vested upon grant and the remaining 80,000 options are scheduled to vest on a quarterly basis over 2 years in equal quarterly instalments of 10,000 options, beginning with the quarter ended March 31, 2024. The options are exercisable within eight years from the grant date. The aggregate grant date fair value of such options was approximately $190. |

| b. | On November 11, 2024, following discussions with the management of the Company, the Board has determined                                      
 that it is advisable and in the best interests of the Company and its stockholders to further amend the Plan, as amended (“Amendment          
 #2”), to reduce the maximum number of shares reserved for issuance under the Plan from 20,000,000 shares of Common Stock to 10,000,000        
 shares of Common Stock. Amendment No. 2 became effective on the date of the approval by the Board of Directors, but it is subject to approval 
 by the Company’s shareholders within 12 months, pursuant to section 422(b)(1) of the Internal Revenue Code.                                   |

| c. | On December 31, 2024, the Board approved a grant under the Company’s Global Share Incentive Plan                                            
 (2021) to an employee of the Predecessor of 740,000 stock options at an exercise price of $0.30 per share. Of the options